| scholarly article | Q13442814 |
| P2093 | author name string | Tao Liu | |
| Ling Zhao | |||
| Wei Zhong | |||
| Zhenyu Jiang | |||
| P2860 | cites work | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Q26859134 |
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis | Q28308126 | ||
| Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain | Q29614225 | ||
| Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment | Q33896725 | ||
| In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial | Q34022672 | ||
| Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 | ||
| 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis | Q34500921 | ||
| Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats | Q34692643 | ||
| Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses | Q35133818 | ||
| Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. | Q35150010 | ||
| Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages | Q35841871 | ||
| Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells | Q37383893 | ||
| Interleukin-22 Secreted by NKp44+ Natural Killer Cells Promotes Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis | Q37624160 | ||
| Recent advances in IL-22 biology. | Q37851777 | ||
| IL-22, not simply a Th17 cytokine | Q38081171 | ||
| Proposal for a new nomenclature of disease-modifying antirheumatic drugs | Q38144973 | ||
| The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy | Q38281473 | ||
| Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. | Q50485305 | ||
| High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. | Q52525666 | ||
| IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts. | Q52643628 | ||
| Loss of IL-22 inhibits autoantibody formation in collagen-induced arthritis in mice. | Q53148065 | ||
| Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis | Q73163237 | ||
| Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice | Q73370075 | ||
| Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease | Q74593708 | ||
| IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration | Q82829186 | ||
| Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study) | Q83608994 | ||
| Effect of methotrexate on serum levels of IL-22 in patients with psoriasis | Q84320861 | ||
| CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis: A Randomized Clinical Trial | Q38411982 | ||
| Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force | Q38476881 | ||
| Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions | Q38673368 | ||
| Biological and pathological activities of interleukin-22. | Q38753752 | ||
| Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients | Q41922047 | ||
| Mechanism of action of leflunomide in rheumatoid arthritis. | Q42541034 | ||
| Methotrexate--how does it really work? | Q43144564 | ||
| Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs | Q43977140 | ||
| Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation | Q44129543 | ||
| Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial | Q44205088 | ||
| Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats | Q45032600 | ||
| Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. | Q45939390 | ||
| The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis | Q46052545 | ||
| IL-22+ CD4+ T cells in patients with rheumatoid arthritis | Q46431837 | ||
| Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis | Q46458365 | ||
| Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis | Q46862865 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| methotrexate | Q422232 | ||
| P304 | page(s) | 41143 | |
| P577 | publication date | 2017-01-24 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide | |
| P478 | volume | 7 |
| Q42042837 | A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease. |
| Q58543113 | Decreased Expression of Sphingosine-1-Phosphate Receptor 1 in the Blood Leukocyte of Rheumatoid Arthritis Patients |
| Q57166646 | Immune Mechanisms and Pathways Targeted in Type 1 Diabetes |
| Q54964170 | Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway. |
| Q92163993 | Lower serum interleukin-22 and interleukin-35 levels are associated with disease status in neuromyelitis optica spectrum disorders |
| Q59352564 | Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314 |
| Q92131178 | The protective and pathogenic roles of IL-17 in viral infections: friend or foe? |
Search more.